CI
IDXX icon

Clal Insurance’s Idexx Laboratories IDXX Stock Holding History

Clal Insurance’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6K Buy
+11
New +$6.17K ﹤0.01% 204
2025
Q3 		– Sell
-20
Closed -$11K – 217
2025
Q2 		$11K Sell
20
-18
-47% -$8.61K ﹤0.01% 185
2025
Q1 		$16K Buy
38
+30
+375% +$13K ﹤0.01% 172
2024
Q4 		$3K Buy
+8
New +$3.51K ﹤0.01% 162

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clal Insurance's IDXX Position: Q2 2026 in Review

Clal Insurance opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 11 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #204 among its holdings. This is a return to the name: Clal Insurance previously reported a position in IDXX as recently as Q2 2025.

Clal Insurance first reported a position in IDXX in Q4 2024 and has held it in 4 quarters since. The position peaked at $16K in Q1 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clal Insurance held 11 shares of Idexx Laboratories worth $6K as of Q2 2026.
  • Idexx Laboratories was a new Clal Insurance position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #204 holding.
  • Clal Insurance first reported a position in Idexx Laboratories in Q4 2024 and has held it in 4 quarters since.
  • Clal Insurance's Idexx Laboratories position peaked at $16K in Q1 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.